BPH (Benign Prostatic Hyperplasia)
0
Pipeline Programs
3
Companies
3
Clinical Trials
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
3 companies ranked by most advanced pipeline stage
Butterfly BiosciencesCA - Marina del Rey
1 programButterfly Prostatic Retraction DeviceN/A1 trial
Active Trials
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
2027
2028
2029
ZenflowZenflow Spring System
Butterfly BiosciencesButterfly Prostatic Retraction Device
ZenflowZenflow Spring System
Clinical Trials (3)
Total enrollment: 824 patients across 3 trials
Prospective Post Market Clinical Registry for the Zenflow Spring System - A Minimally Invasive Treatment for LUTS Associated With BPH Spring System Registry
Start: Jun 2026Est. completion: Sep 2028300 patients
N/ANot Yet Recruiting
Butterfly Pivotal Study
Start: Apr 2022Est. completion: Dec 2029245 patients
N/AActive Not Recruiting
Safety and Effectiveness Study of the Zenflow Spring System
Start: Sep 2021Est. completion: Jun 2026279 patients
N/AActive Not Recruiting
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
3 companies competing in this space
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.